Haemonetics Corporation (HAE)

Haemonetics Income Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 29, 2025	Mar 30, 2024	Apr 1, 2023	Apr 2, 2022	Apr 3, 2021
Revenue	1,361	1,309	1,169	993.2	870.46
Revenue Growth (YoY)	3.96%	12.01%	17.67%	14.10%	-11.94%
Cost of Revenue	582.28	597.14	545.79	462.43	442.02
Gross Profit	778.55	711.92	622.87	530.77	428.45
Selling, General & Admin	422.05	420.82	373.95	332.2	263.83
Research & Development	61.13	52.23	49.08	45.98	31.69
Operating Expenses	531.45	505.08	455.67	425.6	328.35
Operating Income	247.1	206.84	167.2	105.17	100.1
Interest Expense	-35.9	-19.5	-13	-5.8	-9.4
Currency Exchange Gain (Loss)	-1.53	-	-	-	-
Other Non Operating Income (Expenses)	15.09	6.48	-1.63	-11.32	-4.43
EBT Excluding Unusual Items	224.75	193.82	152.57	88.05	86.26
Merger & Restructuring Charges	-45.91	-33.54	-11.55	-28.82	-25.26
Gain (Loss) on Sale of Assets	-	2	0.38	9.6	32.81
Asset Writedown	-2.39	-10.42	-	-5.2	-20.9
Other Unusual Items	35.62	-	-	-	-
Pretax Income	212.07	151.87	141.4	63.63	72.91
Income Tax Expense	44.39	34.31	26	20.25	-6.56
Net Income	167.68	117.56	115.4	43.38	79.47
Net Income to Common	167.68	117.56	115.4	43.38	79.47
Net Income Growth	42.63%	1.87%	166.05%	-45.42%	3.85%
Shares Outstanding (Basic)	50	51	51	51	51
Shares Outstanding (Diluted)	51	51	51	51	51
Shares Change (YoY)	-1.30%	-0.04%	0.13%	0.12%	-1.01%
EPS (Basic)	3.33	2.32	2.27	0.85	1.57
EPS (Diluted)	3.31	2.29	2.24	0.84	1.55
EPS Growth	44.54%	2.23%	166.67%	-45.81%	4.73%
Free Cash Flow	142.45	143.63	81.73	75.75	71.77
Free Cash Flow Per Share	2.81	2.79	1.59	1.48	1.40
Gross Margin	57.21%	54.38%	53.30%	53.44%	49.22%
Operating Margin	18.16%	15.80%	14.31%	10.59%	11.50%
Profit Margin	12.32%	8.98%	9.88%	4.37%	9.13%
Free Cash Flow Margin	10.47%	10.97%	6.99%	7.63%	8.24%
EBITDA	355.99	295.45	252.01	191.72	184.38
EBITDA Margin	26.16%	22.57%	21.56%	19.30%	21.18%
D&A For EBITDA	108.89	88.62	84.81	86.55	84.29
EBIT	247.1	206.84	167.2	105.17	100.1
EBIT Margin	18.16%	15.80%	14.31%	10.59%	11.50%
Effective Tax Rate	20.93%	22.59%	18.39%	31.83%	-
Advertising Expenses	7.7	7.1	7.2	4.4	2.7

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q